Project Grant HT94252510535
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$574K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,594,419.00 to The Regents of the University of California, San Francisco (UCSF) to conduct radiopathomic mapping of tumor burden for personalized management of IDH-mutant glioma. The award period runs from September 1, 2025 to August 31, 2028. As a leading academic medical center and research institution, UCSF will leverage its expertise in translational...
This Federal Project Grant award for $236,777.00 was provided by the Defense Health Agency to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The funding supports RAPID HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA, a research project aimed at developing advanced imaging techniques to better manage patients with glioma, a type of brain cancer. The award term runs...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $328,000.00 in funding to The Regents of the University of California, San Francisco (UCSF) to investigate intracalvarial drug delivery strategies into skull bone marrow to create an antitumoral myeloid cell immune response to glioblastoma. The award period is from July 1, 2025 to June 30, 2027. As a leading academic medical center and research...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This Project Grant award for $901,906 from the Defense Health Agency supports research to develop "AUTOMATIC RAPID, HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA". The funding is provided through the Military Medical Research and Development program (CFDA 12.420) which focuses on biomedical research to address military and veteran health needs. The research, conducted by the Regents of the University of California, San Francisco (UCSF), aims to...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
This federal Project Grant award in the amount of $565,250 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "ATP CITRATE LYASE AS A DRUGGABLE VULNERABILITY IN MUTANT ISOCITRATE DEHYDROGENASE GLIOMAS", will support research conducted by The Regents of the University of California, San Francisco (UCSF) from September 1, 2024 through August 31, 2027. The research aims to investigate ATP citrate...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,453,501.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on June 1, 2024. The grant supports the development of "Targeted Theranostic Nanopolymers for Imaging and Alpha Radiopharmaceutical Therapy of Prostate Cancer" over a period of 3 years through May 31, 2027. As a leading academic medical center, UCSF will leverage its expertise in biomedical...